Ligand validation:5NUQ

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 5NUQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NUQ_C8E_B_401	30%	87%	0.18	0.946	0.5	0.21	-	-	0	0	43%	0.4286
5NUQ_C8E_A_401	29%	87%	0.185	0.949	0.39	0.31	-	-	3	0	43%	0.4286
5NUQ_C8E_D_401	27%	77%	0.213	0.944	0.33	0.58	-	-	1	0	52%	0.5238
5NUQ_C8E_B_402	20%	87%	0.23	0.934	0.24	0.44	-	-	0	0	43%	0.4286
5NUQ_C8E_H_302	18%	87%	0.251	0.905	0.38	0.32	-	-	2	0	62%	0.619
5NUQ_C8E_D_402	17%	91%	0.281	0.967	0.23	0.35	-	-	3	0	43%	0.4286
5NUQ_C8E_H_301	16%	76%	0.254	0.912	0.37	0.56	-	-	1	0	52%	0.5238
5NUQ_C8E_F_401	8%	80%	0.362	0.948	0.2	0.64	-	-	0	0	43%	0.4286
5NUQ_C8E_A_402	5%	79%	0.416	0.901	0.38	0.49	-	-	1	0	57%	0.5714
2OMF_C8E_A_345	58%	90%	0.062	0.968	0.21	0.38	-	-	0	0	29%	0.2857
1GFP_C8E_A_341	51%	66%	0.112	0.942	0.38	0.92	-	1	0	0	57%	0.5714
1GFQ_C8E_A_345	41%	88%	0.106	0.95	0.24	0.41	-	-	0	0	29%	0.2857
1GFM_C8E_A_353	34%	74%	0.132	0.96	0.43	0.57	-	-	0	0	19%	19.05
4LSE_C8E_A_408	25%	85%	0.153	0.865	0.34	0.41	-	-	1	0	57%	0.5714
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.